Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

ASBPW vs SNDL vs GRWG vs IIPR vs ACB

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ASBPW
Aspire Biopharma Holdings, Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$125K
5Y Perf.-74.7%
SNDL
SNDL Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • CA
Market Cap$376M
5Y Perf.-9.9%
GRWG
GrowGeneration Corp.

Specialty Retail

Consumer CyclicalNASDAQ • US
Market Cap$85M
5Y Perf.+24.6%
IIPR
Innovative Industrial Properties, Inc.

REIT - Industrial

Real EstateNYSE • US
Market Cap$1.62B
5Y Perf.-21.3%
ACB
Aurora Cannabis Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • CA
Market Cap$195M
5Y Perf.-32.7%

ASBPW vs SNDL vs GRWG vs IIPR vs ACB — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ASBPW logoASBPW
SNDL logoSNDL
GRWG logoGRWG
IIPR logoIIPR
ACB logoACB
IndustryBiotechnologyDrug Manufacturers - Specialty & GenericSpecialty RetailREIT - IndustrialDrug Manufacturers - Specialty & Generic
Market Cap$125K$376M$85M$1.62B$195M
Revenue (TTM)$2K$937M$162M$263M$361M
Net Income (TTM)$-32M$-11M$-24M$120M$41M
Gross Margin45.5%27.2%26.8%60.3%62.7%
Operating Margin-10314.0%-0.8%-15.7%46.7%13.3%
Forward P/E13.2x164.2x
Total Debt$1M$170M$29M$394M$104M
Cash & Equiv.$4K$273M$30M$48M$184M

ASBPW vs SNDL vs GRWG vs IIPR vs ACBLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ASBPW
SNDL
GRWG
IIPR
ACB
StockFeb 25May 26Return
Aspire Biopharma Ho… (ASBPW)10025.3-74.7%
SNDL Inc. (SNDL)10090.1-9.9%
GrowGeneration Corp. (GRWG)100124.6+24.6%
Innovative Industri… (IIPR)10078.7-21.3%
Aurora Cannabis Inc. (ACB)10067.3-32.7%

Price return only. Dividends and distributions are not included.

Quick Verdict: ASBPW vs SNDL vs GRWG vs IIPR vs ACB

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: IIPR leads in 4 of 7 categories (5-stock set), making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Aurora Cannabis Inc. is the stronger pick specifically for growth and revenue expansion and operational efficiency and capital deployment. GRWG also leads in specific categories worth noting. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
ASBPW
Aspire Biopharma Holdings, Inc.
The Healthcare Pick

ASBPW lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
SNDL
SNDL Inc.
The Defensive Pick

SNDL is the clearest fit if your priority is sleep-well-at-night and defensive.

  • Lower volatility, beta 1.18, Low D/E 15.4%, current ratio 4.88x
  • Beta 1.18, current ratio 4.88x
Best for: sleep-well-at-night and defensive
GRWG
GrowGeneration Corp.
The Momentum Pick

GRWG ranks third and is worth considering specifically for momentum.

  • +25.7% vs ASBPW's -66.2%
Best for: momentum
IIPR
Innovative Industrial Properties, Inc.
The Real Estate Income Play

IIPR carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 9 yrs, beta 0.92, yield 13.5%
  • 436.4% 10Y total return vs ASBPW's -81.9%
  • Lower P/E (13.2x vs 164.2x)
  • 45.6% margin vs ASBPW's -16K%
Best for: income & stability and long-term compounding
ACB
Aurora Cannabis Inc.
The Growth Play

ACB is the #2 pick in this set and the best alternative if growth exposure is your priority.

  • Rev growth 27.0%, EPS growth 102.2%, 3Y rev CAGR 15.8%
  • 27.0% revenue growth vs ASBPW's -25.4%
  • 5.2% ROA vs ASBPW's -13.2%
Best for: growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthACB logoACB27.0% revenue growth vs ASBPW's -25.4%
ValueIIPR logoIIPRLower P/E (13.2x vs 164.2x)
Quality / MarginsIIPR logoIIPR45.6% margin vs ASBPW's -16K%
Stability / SafetyIIPR logoIIPRBeta 0.92 vs ASBPW's 3.15
DividendsIIPR logoIIPR13.5% yield; 9-year raise streak; the other 4 pay no meaningful dividend
Momentum (1Y)GRWG logoGRWG+25.7% vs ASBPW's -66.2%
Efficiency (ROA)ACB logoACB5.2% ROA vs ASBPW's -13.2%

ASBPW vs SNDL vs GRWG vs IIPR vs ACB — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ASBPWAspire Biopharma Holdings, Inc.

Segment breakdown not available.

SNDLSNDL Inc.
FY 2022
Cannabis
100.0%$62M
GRWGGrowGeneration Corp.
FY 2024
Storage Solutions
100.0%$25M
IIPRInnovative Industrial Properties, Inc.

Segment breakdown not available.

ACBAurora Cannabis Inc.

Segment breakdown not available.

ASBPW vs SNDL vs GRWG vs IIPR vs ACB — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLIIPRLAGGINGACB

Income & Cash Flow (Last 12 Months)

IIPR leads this category, winning 3 of 6 comparable metrics.

SNDL is the larger business by revenue, generating $937M annually — 482943.3x ASBPW's $1,941. IIPR is the more profitable business, keeping 45.6% of every revenue dollar as net income compared to ASBPW's -16351.8%. On growth, ACB holds the edge at +6.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricASBPW logoASBPWAspire Biopharma …SNDL logoSNDLSNDL Inc.GRWG logoGRWGGrowGeneration Co…IIPR logoIIPRInnovative Indust…ACB logoACBAurora Cannabis I…
RevenueTrailing 12 months$1,941$937M$162M$263M$361M
EBITDAEarnings before interest/tax-$28M$49M-$14M$197M$71M
Net IncomeAfter-tax profit-$32M-$11M-$24M$120M$41M
Free Cash FlowCash after capex-$4M$53M-$10M$144M-$31M
Gross MarginGross profit ÷ Revenue+45.5%+27.2%+26.8%+60.3%+62.7%
Operating MarginEBIT ÷ Revenue-10314.0%-0.8%-15.7%+46.7%+13.3%
Net MarginNet income ÷ Revenue-16351.8%-1.2%-14.9%+45.6%+11.2%
FCF MarginFCF ÷ Revenue-1811.5%+5.6%-6.2%+54.7%-8.7%
Rev. Growth (YoY)Latest quarter vs prior year-4.4%+1.0%-3.8%+6.8%
EPS Growth (YoY)Latest quarter vs prior year+46.0%+32.8%+69.2%-1.0%-94.5%
IIPR leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

Evenly matched — SNDL and ACB each lead in 2 of 5 comparable metrics.

At 14.4x trailing earnings, IIPR trades at a 91% valuation discount to ACB's 164.2x P/E. On an enterprise value basis, ACB's 6.7x EV/EBITDA is more attractive than IIPR's 9.9x.

MetricASBPW logoASBPWAspire Biopharma …SNDL logoSNDLSNDL Inc.GRWG logoGRWGGrowGeneration Co…IIPR logoIIPRInnovative Indust…ACB logoACBAurora Cannabis I…
Market CapShares × price$125,312$376M$85M$1.6B$195M
Enterprise ValueMkt cap + debt − cash$1M$301M$84M$2.0B$136M
Trailing P/EPrice ÷ TTM EPS-0.01x-32.97x-3.55x14.40x164.21x
Forward P/EPrice ÷ next-FY EPS est.13.17x
PEG RatioP/E ÷ EPS growth rate3.85x
EV / EBITDAEnterprise value multiple7.91x9.91x6.73x
Price / SalesMarket cap ÷ Revenue0.54x0.53x6.08x0.77x
Price / BookPrice ÷ Book value/share0.46x0.87x0.87x0.43x
Price / FCFMarket cap ÷ FCF8.83x9.26x
Evenly matched — SNDL and ACB each lead in 2 of 5 comparable metrics.

Profitability & Efficiency

Evenly matched — IIPR and ACB each lead in 3 of 9 comparable metrics.

ACB delivers a 7.2% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $-23 for GRWG. SNDL carries lower financial leverage with a 0.15x debt-to-equity ratio, signaling a more conservative balance sheet compared to GRWG's 0.30x. On the Piotroski fundamental quality scale (0–9), ACB scores 7/9 vs ASBPW's 3/9, reflecting strong financial health.

MetricASBPW logoASBPWAspire Biopharma …SNDL logoSNDLSNDL Inc.GRWG logoGRWGGrowGeneration Co…IIPR logoIIPRInnovative Indust…ACB logoACBAurora Cannabis I…
ROE (TTM)Return on equity-1.0%-22.9%+6.4%+7.2%
ROA (TTM)Return on assets-13.2%-0.8%-15.2%+5.1%+5.2%
ROICReturn on invested capital-0.3%-16.9%+4.3%+0.7%
ROCEReturn on capital employed-0.4%-18.8%+5.8%+0.7%
Piotroski ScoreFundamental quality 0–936647
Debt / EquityFinancial leverage0.15x0.30x0.21x0.17x
Net DebtTotal debt minus cash$1M-$102M-$929,000$346M-$80M
Cash & Equiv.Liquid assets$3,633$273M$30M$48M$184M
Total DebtShort + long-term debt$1M$170M$29M$394M$104M
Interest CoverageEBIT ÷ Interest expense-10.51x-1.16x6.67x6.27x
Evenly matched — IIPR and ACB each lead in 3 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

IIPR leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in IIPR five years ago would be worth $4,999 today (with dividends reinvested), compared to $330 for GRWG. Over the past 12 months, GRWG leads with a +25.7% total return vs ASBPW's -66.2%. The 3-year compound annual growth rate (CAGR) favors IIPR at 4.5% vs ASBPW's -43.4% — a key indicator of consistent wealth creation.

MetricASBPW logoASBPWAspire Biopharma …SNDL logoSNDLSNDL Inc.GRWG logoGRWGGrowGeneration Co…IIPR logoIIPRInnovative Indust…ACB logoACBAurora Cannabis I…
YTD ReturnYear-to-date-18.3%-16.7%-7.8%+18.3%-21.0%
1-Year ReturnPast 12 months-66.2%+11.5%+25.7%+20.3%-25.3%
3-Year ReturnCumulative with dividends-81.9%-16.2%-62.0%+14.1%-47.2%
5-Year ReturnCumulative with dividends-81.9%-81.1%-96.7%-50.0%-96.1%
10-Year ReturnCumulative with dividends-81.9%-98.3%-75.7%+436.4%-92.0%
CAGR (3Y)Annualised 3-year return-43.4%-5.7%-27.6%+4.5%-19.2%
IIPR leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

IIPR leads this category, winning 2 of 2 comparable metrics.

IIPR is the less volatile stock with a 0.92 beta — it tends to amplify market swings less than ASBPW's 3.15 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IIPR currently trades 92.2% from its 52-week high vs ASBPW's 16.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricASBPW logoASBPWAspire Biopharma …SNDL logoSNDLSNDL Inc.GRWG logoGRWGGrowGeneration Co…IIPR logoIIPRInnovative Indust…ACB logoACBAurora Cannabis I…
Beta (5Y)Sensitivity to S&P 5003.15x1.18x1.27x0.92x1.81x
52-Week HighHighest price in past year$0.09$2.89$2.40$61.40$6.67
52-Week LowLowest price in past year$0.01$1.15$0.87$44.58$3.07
% of 52W HighCurrent price vs 52-week peak+16.9%+50.2%+59.2%+92.2%+51.4%
RSI (14)Momentum oscillator 0–10052.449.763.259.352.2
Avg Volume (50D)Average daily shares traded23K1.9M476K303K979K
IIPR leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: SNDL as "Hold", IIPR as "Hold", ACB as "Hold". Consensus price targets imply 172.4% upside for SNDL (target: $4) vs -22.3% for IIPR (target: $44). IIPR is the only dividend payer here at 13.46% yield — a key consideration for income-focused portfolios.

MetricASBPW logoASBPWAspire Biopharma …SNDL logoSNDLSNDL Inc.GRWG logoGRWGGrowGeneration Co…IIPR logoIIPRInnovative Indust…ACB logoACBAurora Cannabis I…
Analyst RatingConsensus buy/hold/sellHoldHoldHold
Price TargetConsensus 12-month target$3.95$44.00$5.92
# AnalystsCovering analysts61114
Dividend YieldAnnual dividend ÷ price+13.5%
Dividend StreakConsecutive years of raises9
Dividend / ShareAnnual DPS$7.62
Buyback YieldShare repurchases ÷ mkt cap0.0%+3.0%0.0%+1.2%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

IIPR leads in 3 of 6 categories — strongest in Income & Cash Flow and Total Returns. 2 categories are tied.

Best OverallInnovative Industrial Prope… (IIPR)Leads 3 of 6 categories
Loading custom metrics...

ASBPW vs SNDL vs GRWG vs IIPR vs ACB: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is ASBPW or SNDL or GRWG or IIPR or ACB a better buy right now?

For growth investors, Aurora Cannabis Inc.

(ACB) is the stronger pick with 27. 0% revenue growth year-over-year, versus -14. 4% for GrowGeneration Corp. (GRWG). Innovative Industrial Properties, Inc. (IIPR) offers the better valuation at 14. 4x trailing P/E (13. 2x forward), making it the more compelling value choice. Analysts rate SNDL Inc. (SNDL) a "Hold" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — ASBPW or SNDL or GRWG or IIPR or ACB?

On trailing P/E, Innovative Industrial Properties, Inc.

(IIPR) is the cheapest at 14. 4x versus Aurora Cannabis Inc. at 164. 2x.

03

Which is the better long-term investment — ASBPW or SNDL or GRWG or IIPR or ACB?

Over the past 5 years, Innovative Industrial Properties, Inc.

(IIPR) delivered a total return of -50. 0%, compared to -96. 7% for GrowGeneration Corp. (GRWG). Over 10 years, the gap is even starker: IIPR returned +436. 4% versus SNDL's -98. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — ASBPW or SNDL or GRWG or IIPR or ACB?

By beta (market sensitivity over 5 years), Innovative Industrial Properties, Inc.

(IIPR) is the lower-risk stock at 0. 92β versus Aspire Biopharma Holdings, Inc. 's 3. 15β — meaning ASBPW is approximately 244% more volatile than IIPR relative to the S&P 500. On balance sheet safety, SNDL Inc. (SNDL) carries a lower debt/equity ratio of 15% versus 30% for GrowGeneration Corp. — giving it more financial flexibility in a downturn.

05

Which is growing faster — ASBPW or SNDL or GRWG or IIPR or ACB?

By revenue growth (latest reported year), Aurora Cannabis Inc.

(ACB) is pulling ahead at 27. 0% versus -14. 4% for GrowGeneration Corp. (GRWG). On earnings-per-share growth, the picture is similar: Aurora Cannabis Inc. grew EPS 102. 2% year-over-year, compared to -381. 5% for Aspire Biopharma Holdings, Inc.. Over a 3-year CAGR, ACB leads at 15. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — ASBPW or SNDL or GRWG or IIPR or ACB?

Innovative Industrial Properties, Inc.

(IIPR) is the more profitable company, earning 43. 0% net margin versus -16351. 8% for Aspire Biopharma Holdings, Inc. — meaning it keeps 43. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IIPR leads at 46. 7% versus -10314. 0% for ASBPW. At the gross margin level — before operating expenses — IIPR leads at 88. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is ASBPW or SNDL or GRWG or IIPR or ACB more undervalued right now?

Analyst consensus price targets imply the most upside for SNDL: 172.

4% to $3. 95.

08

Which pays a better dividend — ASBPW or SNDL or GRWG or IIPR or ACB?

In this comparison, IIPR (13.

5% yield) pays a dividend. ASBPW, SNDL, GRWG, ACB do not pay a meaningful dividend and should not be held primarily for income.

09

Is ASBPW or SNDL or GRWG or IIPR or ACB better for a retirement portfolio?

For long-horizon retirement investors, Innovative Industrial Properties, Inc.

(IIPR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 92), 13. 5% yield, +436. 4% 10Y return). Aspire Biopharma Holdings, Inc. (ASBPW) carries a higher beta of 3. 15 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IIPR: +436. 4%, ASBPW: -81. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between ASBPW and SNDL and GRWG and IIPR and ACB?

These companies operate in different sectors (ASBPW (Healthcare) and SNDL (Healthcare) and GRWG (Consumer Cyclical) and IIPR (Real Estate) and ACB (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ASBPW is a small-cap quality compounder stock; SNDL is a small-cap quality compounder stock; GRWG is a small-cap quality compounder stock; IIPR is a small-cap deep-value stock; ACB is a small-cap high-growth stock. IIPR pays a dividend while ASBPW, SNDL, GRWG, ACB do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

ASBPW

Quality Business

  • Sector: Healthcare
  • Market Cap > $20B
  • Gross Margin > 27%
Run This Screen
Stocks Like

SNDL

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 16%
Run This Screen
Stocks Like

GRWG

Quality Business

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Gross Margin > 16%
Run This Screen
Stocks Like

IIPR

Dividend Mega-Cap Quality

  • Sector: Real Estate
  • Market Cap > $100B
  • Net Margin > 27%
  • Dividend Yield > 5.3%
Run This Screen
Stocks Like

ACB

Steady Growth Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 6%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.